Skip to content
10-Q

Quarterly Report

APELLIS PHARMACEUTICALS, INC.

0001193125-25-257374

← back to feed
Filed
Oct 30, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 23, 2025 126.53M sh
Shares Diluted Q3 2025 · Sep 30, 2025 130.07M sh
Shares Diluted Q3 2025 · Sep 30, 2025 129.65M sh
Shares Diluted Q3 2025 · Sep 30, 2024 124.23M sh
Shares Diluted Q3 2025 · Sep 30, 2024 123.7M sh
Capex Q3 2025 · Sep 30, 2025 $205K
Capex Q3 2025 · Sep 30, 2024 $383K
Operating Cash Flow Q3 2025 · Sep 30, 2025 $59.5M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$107.23M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $479.17M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $411.29M
Cash And Equivalents Q3 2025 · Sep 30, 2024 $396.86M
Stockholders Equity Q3 2025 · Sep 30, 2025 $401.17M
Stockholders Equity Q3 2025 · Jun 30, 2025 $156.31M
Stockholders Equity Q3 2025 · Mar 31, 2025 $164.22M
Stockholders Equity Q3 2025 · Dec 31, 2024 $228.54M
Stockholders Equity Q3 2025 · Sep 30, 2024 $237.12M
Stockholders Equity Q3 2025 · Jun 30, 2024 $264.33M
Stockholders Equity Q3 2025 · Mar 31, 2024 $266.68M
Stockholders Equity Q3 2025 · Dec 31, 2023 $194.52M
Current Liabilities Q3 2025 · Sep 30, 2025 $279.53M
Current Liabilities Q3 2025 · Dec 31, 2024 $185.51M
Total Liabilities Q3 2025 · Sep 30, 2025 $657.56M
Total Liabilities Q3 2025 · Dec 31, 2024 $656.51M
Current Assets Q3 2025 · Sep 30, 2025 $990.68M
Current Assets Q3 2025 · Dec 31, 2024 $788.95M
Total Assets Q3 2025 · Sep 30, 2025 $1.06B
Total Assets Q3 2025 · Dec 31, 2024 $885.05M
Eps Diluted Q3 2025 · Sep 30, 2025 $1.67
Eps Diluted Q3 2025 · Sep 30, 2025 $0.65
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.46
Eps Diluted Q3 2025 · Sep 30, 2024 −$1.31
Eps Basic Q3 2025 · Sep 30, 2025 $1.71
Eps Basic Q3 2025 · Sep 30, 2025 $0.65
Eps Basic Q3 2025 · Sep 30, 2024 −$0.46
Eps Basic Q3 2025 · Sep 30, 2024 −$1.31
Sga Expense Q3 2025 · Sep 30, 2025 $142.68M
Sga Expense Q3 2025 · Sep 30, 2025 $403.16M
Sga Expense Q3 2025 · Sep 30, 2024 $121.98M
Sga Expense Q3 2025 · Sep 30, 2024 $379.57M
Rd Expense Q3 2025 · Sep 30, 2025 $68.19M
Rd Expense Q3 2025 · Sep 30, 2025 $221.62M
Rd Expense Q3 2025 · Sep 30, 2024 $88.57M
Rd Expense Q3 2025 · Sep 30, 2024 $251.22M
Net Income Q3 2025 · Sep 30, 2025 $215.72M
Net Income Q3 2025 · Sep 30, 2025 $81.34M
Net Income Q3 2025 · Jun 30, 2025 −$42.15M
Net Income Q3 2025 · Mar 31, 2025 −$92.23M
Net Income Q3 2025 · Sep 30, 2024 −$57.45M
Net Income Q3 2025 · Sep 30, 2024 −$161.53M
Net Income Q3 2025 · Jun 30, 2024 −$37.66M
Net Income Q3 2025 · Mar 31, 2024 −$66.42M
Operating Income Q3 2025 · Sep 30, 2025 $223.18M
Operating Income Q3 2025 · Sep 30, 2025 $106.57M
Operating Income Q3 2025 · Sep 30, 2024 −$47.28M
Operating Income Q3 2025 · Sep 30, 2024 −$138.82M
Revenue Q3 2025 · Sep 30, 2025 $458.58M
Revenue Q3 2025 · Sep 30, 2025 $803.87M
Revenue Q3 2025 · Sep 30, 2024 $196.83M
Revenue Q3 2025 · Sep 30, 2024 $568.84M